DK159163C - Fremgangsmaade til fremstilling af et tarm-glucagon-antistof - Google Patents
Fremgangsmaade til fremstilling af et tarm-glucagon-antistofInfo
- Publication number
- DK159163C DK159163C DK222081A DK222081A DK159163C DK 159163 C DK159163 C DK 159163C DK 222081 A DK222081 A DK 222081A DK 222081 A DK222081 A DK 222081A DK 159163 C DK159163 C DK 159163C
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- manufacturing
- gas
- glucagon antibody
- glucagon
- Prior art date
Links
- 102000051325 Glucagon Human genes 0.000 title 1
- 108060003199 Glucagon Proteins 0.000 title 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title 1
- 229960004666 glucagon Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/822—Identified hapten
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6804080A JPS56163456A (en) | 1980-05-21 | 1980-05-21 | Preparation of antigen |
| JP6804080 | 1980-05-21 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK222081A DK222081A (da) | 1981-11-22 |
| DK159163B DK159163B (da) | 1990-09-10 |
| DK159163C true DK159163C (da) | 1991-02-11 |
Family
ID=13362282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK222081A DK159163C (da) | 1980-05-21 | 1981-05-20 | Fremgangsmaade til fremstilling af et tarm-glucagon-antistof |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4407965A (en, 2012) |
| JP (1) | JPS56163456A (en, 2012) |
| BE (1) | BE888906A (en, 2012) |
| DE (1) | DE3120312C2 (en, 2012) |
| DK (1) | DK159163C (en, 2012) |
| FR (1) | FR2482861A1 (en, 2012) |
| GB (1) | GB2079289B (en, 2012) |
| SE (1) | SE454301B (en, 2012) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1249395A (en) * | 1982-09-30 | 1989-01-24 | Tetsuya Tachikawa | Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies |
| CA1256795A (en) * | 1983-12-28 | 1989-07-04 | Dennis A. Carson | Anti-idiotype antibodies induced by synthetic polypeptides |
| US4545985A (en) * | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
| GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
| US5116725A (en) * | 1984-08-08 | 1992-05-26 | Scripps Clinic And Research Foundation | Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides |
| US4654419A (en) * | 1984-08-08 | 1987-03-31 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| WO1986001834A1 (en) * | 1984-09-19 | 1986-03-27 | The Regents Of The University Of California | Retroviral polypeptides associated with human cellular transformation |
| US4732863A (en) * | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
| JPH0792458B2 (ja) * | 1986-03-14 | 1995-10-09 | 郁男 山科 | 糖鎖特異抗体アツセイプレ−ト及びその製造方法 |
| US5202270A (en) * | 1986-05-15 | 1993-04-13 | Abbott Laboratories | Cocaine and cocaine metabolites assay tracers, immunogens and antibodies |
| US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
| SG11201701711VA (en) | 2014-09-16 | 2017-04-27 | Regeneron Pharma | Anti-glucagon antibodies and uses thereof |
| MX385598B (es) | 2016-08-30 | 2025-03-18 | Regeneron Pharma | Anticuerpo inhibidor para usarse para tratar la resistencia severa a la insulina. |
| WO2018075792A1 (en) | 2016-10-20 | 2018-04-26 | Regeneron Pharmaceuticals, Inc. | Methods of lowering blood glucose levels |
| JP2020531532A (ja) | 2017-08-22 | 2020-11-05 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | グルカゴン受容体シグナル伝達に干渉することによって尿素サイクル異常症を治療する方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5836308B2 (ja) * | 1977-02-10 | 1983-08-08 | 大塚製薬株式会社 | 抗体の製造方法 |
| US4206199A (en) * | 1977-07-22 | 1980-06-03 | Takeda Chemical Industries, Ltd. | Novel glucagon fragment and its derivatives |
-
1980
- 1980-05-21 JP JP6804080A patent/JPS56163456A/ja active Granted
-
1981
- 1981-05-20 DK DK222081A patent/DK159163C/da not_active IP Right Cessation
- 1981-05-20 SE SE8103198A patent/SE454301B/sv not_active IP Right Cessation
- 1981-05-21 US US06/265,926 patent/US4407965A/en not_active Expired - Lifetime
- 1981-05-21 FR FR8110140A patent/FR2482861A1/fr active Granted
- 1981-05-21 DE DE3120312A patent/DE3120312C2/de not_active Expired
- 1981-05-21 GB GB8115648A patent/GB2079289B/en not_active Expired
- 1981-05-21 BE BE0/204863A patent/BE888906A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE454301B (sv) | 1988-04-18 |
| DK222081A (da) | 1981-11-22 |
| DK159163B (da) | 1990-09-10 |
| DE3120312C2 (de) | 1985-08-29 |
| BE888906A (fr) | 1981-11-23 |
| GB2079289B (en) | 1983-10-26 |
| GB2079289A (en) | 1982-01-20 |
| DE3120312A1 (de) | 1982-03-04 |
| FR2482861A1 (fr) | 1981-11-27 |
| JPS56163456A (en) | 1981-12-16 |
| JPS6223822B2 (en, 2012) | 1987-05-25 |
| FR2482861B1 (en, 2012) | 1983-09-09 |
| SE8103198L (sv) | 1981-11-22 |
| US4407965A (en) | 1983-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK362781A (da) | Fremgangsmaade til fremstilling af en kapsel | |
| DK154333C (da) | Fremgangsmaade til fremstilling af et formstofnet | |
| DK329079A (da) | Fremgangsmaade til fremstilling af et bygningselement | |
| DK156624C (da) | Fremgangsmaade til fremstilling af en gel med gastransporterende egenskaber | |
| DK153796C (da) | Fremgangsmaade til fremstilling af et polyurethanskum. | |
| DK127780A (da) | Fremgangsmaade til fremstilling af mikrokapsler specielt mikrokapsler indeholdende et herbicid | |
| DK157977C (da) | Fremgangsmaade til fremstilling af et vaevsklaebestof | |
| DK159163C (da) | Fremgangsmaade til fremstilling af et tarm-glucagon-antistof | |
| DK343581A (da) | Fremgangsmaade til fremstilling af et triamterenpraeparat | |
| DK157340C (da) | Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof | |
| DK150914C (da) | Byggesaet til opbygning af et gelaender | |
| DK1584D0 (da) | Fremgangsmade til fremstilling af et gitterkernesandwichelement | |
| DK140181A (da) | Fremgangsmaade til fremstilling af en taendingselektrode | |
| DK528379A (da) | Fremgangsmaade til fremstilling af et byggeelement | |
| DK387081A (da) | Apparat til frembringelse af en frem-og tilbagegaaende bevaegelse | |
| NO813270L (no) | Fremgangsmaate til fremstilling av et leddet belte | |
| DK44181A (da) | Fremgangsmaade til fremstilling af humant relaxin | |
| DK404181A (da) | Fremgangsmaade til fremstilling af cephalosporiner | |
| DK150336C (da) | Fremgangsmaade til fremstilling af en forstaerket ketsjerramme | |
| DK87082A (da) | Fremgangsmaade til fremstilling af cemnetklinker | |
| DK223781A (da) | Fremgangsmaade til fremstilling af modificerede chrysotilasbestfibre | |
| DK292681A (da) | Fremgangsmaade til fremstilling af et macrolid | |
| DK471181A (da) | Fremgangsmaade til fremstilling af et pyrimidinderivat | |
| DK153326C (da) | Fremgangsmaade til fremstilling af azoforbindelser | |
| DK148636C (da) | Fremgangsmaade til fremstilling af et lagringsbestandigt braendsel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |